- Pluristem Therapeutics ( NASDAQ: PSTI ) said it changed its name to Pluri Inc. to reflect a strategy of using its 3D cell expansion technology to develop cell-based products for several fields beyond medicine.
- The company also changed its ticker symbol to PLUR from PSTI, and as of July 26 will trade under the new ticker.
- "Increasing our activity across multiple verticals means we can do even more to improve human life and contribute to a more sustainable planet," said Pluri's President and CEO Yaky Yanay.
- Earlier in July, the company's phase 3 trial of PLX-PAD cells to treat muscle injury after hip fracture surgery failed its main goal.
- PSTI +2.91% to $1.06 premarket July 25
For further details see:
Pluristem Therapeutics renames as Pluri